Are there any domestic alternatives to Valganciclovir? Alternatives and Comparative Efficacy

Valganciclovir is one of the core oral antiviral drugs currently widely used clinically to prevent and treat cytomegalovirus (CMV) infection, especially in organ transplant recipients and patients with HIV combined with CMV retinitis. Since the drug was originally developed and marketed by Roche, the price of the original version has been relatively high for a long time. Therefore, many patients and doctors are concerned about whether there are domestic alternative drugs. In fact, with the continuous advancement of the research and development of generic drugs in our country, there is currently a domestic generic version of valganciclovir, which has been approved for marketing by the State Food and Drug Administration.

At present, many well-known pharmaceutical companies in China, such as Shanghai Shanghai Pharmaceuticals Chinese and Western Pharmaceuticals, have successfully launched generic versions of valganciclovir tablets and passed the consistency evaluation, and their effectiveness and safety have been clinically verified. These domestic alternative drugs are basically equivalent to the original drug Vancevir in terms of chemical structure, body metabolism and efficacy. They can achieve equivalent substitutions and be used for the same indications, including the prevention of CMV infection in patients with solid organ transplants and the treatment of HIV combined with CMV retinitis.

In terms of price, domestically produced valganciclovir has significant economic advantages over original drugs due to its lower cost and the fact that some products are included in the national medical insurance catalog. The domestic version sold by some hospital pharmacies is even less than one-third of the original drug, which greatly reduces the patient's long-term medication burden. This alternative is particularly important for patients who require long-term maintenance therapy.

It should be noted that although domestically produced valganciclovir has been clinically approved, patients should still use it under the guidance of a doctor. In particular, blood and renal function should be closely monitored during medication under immunosuppression to avoid possible adverse reactions.

Reference materials:https://go.drugbank.com/drugs/DB01610